These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30977389)

  • 81. A novel mutation in the E-cadherin gene in the first family with hereditary diffuse gastric cancer reported in Spain.
    Rodriguez-Sanjuan JC; Fontalba A; Mayorga M; Bordin MC; Hyland SJ; Trugeda S; Garcia RA; Gomez-Fleitas M; Fernandez F; Caldas C; Fernandez-Luna JL
    Eur J Surg Oncol; 2006 Dec; 32(10):1110-3. PubMed ID: 16870389
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Novel germline CDH1 mutations in hereditary diffuse gastric cancer families.
    Humar B; Toro T; Graziano F; Müller H; Dobbie Z; Kwang-Yang H; Eng C; Hampel H; Gilbert D; Winship I; Parry S; Ward R; Findlay M; Christian A; Tucker M; Tucker K; Merriman T; Guilford P
    Hum Mutat; 2002 May; 19(5):518-25. PubMed ID: 11968084
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Familial gastric cancer].
    Nihei Z; Iida S; Sugihara K
    Nihon Rinsho; 2000 Jul; 58(7):1523-6. PubMed ID: 10921336
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A novel truncating mutation in the E-cadherin gene in the first Iranian family with hereditary diffuse gastric cancer.
    Ghaffari SR; Rafati M; Sabokbar T; Dastan J
    Eur J Surg Oncol; 2010 Jun; 36(6):559-62. PubMed ID: 20471195
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing.
    Vogelaar IP; van der Post RS; van Krieken JHJ; Spruijt L; van Zelst-Stams WA; Kets CM; Lubinski J; Jakubowska A; Teodorczyk U; Aalfs CM; van Hest LP; Pinheiro H; Oliveira C; Jhangiani SN; Muzny DM; Gibbs RA; Lupski JR; de Ligt J; Vissers LELM; Hoischen A; Gilissen C; van de Vorst M; Goeman JJ; Schackert HK; Ranzani GN; Molinaro V; Gómez García EB; Hes FJ; Holinski-Feder E; Genuardi M; Ausems MGEM; Sijmons RH; Wagner A; van der Kolk LE; Bjørnevoll I; Høberg-Vetti H; van Kessel AG; Kuiper RP; Ligtenberg MJL; Hoogerbrugge N
    Eur J Hum Genet; 2017 Nov; 25(11):1246-1252. PubMed ID: 28875981
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Genetics of hereditary diffuse gastric cancer: progress and future challenges.
    Suriano G; Ferreira P; Mateus AR; Correia J; Henriques L; Seruca R
    Future Oncol; 2006 Jun; 2(3):363-70. PubMed ID: 16787116
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Diffuse gastric cancer.
    Framp A
    Gastroenterol Nurs; 2006; 29(3):232-6; quiz 236-8. PubMed ID: 16770139
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Risk-reducing mastectomy in germline CDH1 mutation carriers: Pathologic findings.
    Gianella CA; Bendito B; Iglesias C; Bengoechea MP; Miñón C; Ruiz A
    Breast J; 2020 Mar; 26(3):583-584. PubMed ID: 31538378
    [No Abstract]   [Full Text] [Related]  

  • 89. Different types of epithelial cadherin alterations play different roles in human carcinogenesis.
    Sobrinho-Simões M; Oliveira C
    Adv Anat Pathol; 2002 Nov; 9(6):329-37. PubMed ID: 12409641
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Paving the Way: A Grounded Theory of Discovery and Decision Making for Individuals With the CDH1 Marker.
    Hersperger CL; Boucher J; Theroux R
    Oncol Nurs Forum; 2020 Jul; 47(4):446-456. PubMed ID: 32555552
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Molecular profiling of gastric cancer: toward personalized cancer medicine.
    Nadauld LD; Ford JM
    J Clin Oncol; 2013 Mar; 31(7):838-9. PubMed ID: 23341521
    [No Abstract]   [Full Text] [Related]  

  • 92. Association of e-cadherin gene CDH1 polymorphism -160 C/A with susceptibility to develop vitiligo.
    Kubelis-López DE; Zapata-Salazar NA; Salinas-Santander MA; Sánchez-Domínguez CN; Morlett-Chávez JA; Ocampo-Candiani J
    An Bras Dermatol; 2023; 98(3):376-378. PubMed ID: 36754648
    [No Abstract]   [Full Text] [Related]  

  • 93. Family history and the risk of gastric cancer.
    Yaghoobi M; Bijarchi R; Narod SA
    Br J Cancer; 2010 Jan; 102(2):237-42. PubMed ID: 19888225
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Gastric cancer. A fleeting glimpse at its genetic evidences.
    Lopasso FP
    Arq Gastroenterol; 2014; 51(2):77-8. PubMed ID: 25003255
    [No Abstract]   [Full Text] [Related]  

  • 95. The differential diagnosis of a TP53 genetic testing result.
    MacFarland SP; Maxwell KN
    Genet Med; 2018 Aug; 20(8):806-808. PubMed ID: 29323666
    [No Abstract]   [Full Text] [Related]  

  • 96. Genetic testing might miss some inherited mutations .
    Bosch X
    Lancet Oncol; 2006 May; 7(5):372. PubMed ID: 16696169
    [No Abstract]   [Full Text] [Related]  

  • 97. Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations.
    Corso G; Magnoni F; Nicastro V; Bagnardi V; Trovato CM; Veronesi P
    Semin Oncol; 2022 Apr; 49(2):130-135. PubMed ID: 35393124
    [TBL] [Abstract][Full Text] [Related]  

  • 98. HOXA10 improves endometrial receptivity by upregulating E-cadherin†.
    Bi Y; Huang W; Yuan L; Chen S; Liao S; Fu X; Liu B; Yang Y
    Biol Reprod; 2022 May; 106(5):992-999. PubMed ID: 35044439
    [TBL] [Abstract][Full Text] [Related]  

  • 99. When E-Cadherin Becomes Unstuck in Cancer.
    O'Driscoll L
    N Engl J Med; 2020 Aug; 383(9):871-873. PubMed ID: 32846069
    [No Abstract]   [Full Text] [Related]  

  • 100. Current advances and challenges in Managing Hereditary Diffuse Gastric Cancer (HDGC): a narrative review.
    van der Sluis L; van Dieren JM; van der Post RS; Bisseling TM
    Hered Cancer Clin Pract; 2024 Oct; 22(1):21. PubMed ID: 39379994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.